Laparoscopic Radical Cystectomy in a Low-Middle Income Country: A 5-Year Review of a Single Institution; Operative Data, Oncologic Results and Morbidity
Introduction and Objective: Laparoscopic radical cystectomy (LRC) is an alternative to open approach with lower morbidity and better oncologic outcome. We aim to share our experience on laparoscopic radical cystectomy and to evaluate our morbidity and oncological outcome in our settings. Methodology: An observational study in the Douala Medico-Surgical Urology Centre on 5 patients who underwent laparoscopic cystectomy with or without lymph node dissection and external urine diversion between April 2014 to July 2016 was conducted. The overall survival rate was subsequently estimated. Results: Four men and one woman underwent laparoscopic radical cystectomy during the 5-year study period with a mean age of 54.5-year-old. Three patients were submitted to ileal conduits, one to neobladders, and one patient to uretero-cutaneostomies. The mean operative time was 300 ± 17 minutes and the mean length of hospital stay was 9 ± 3 days. Three patients had minor complications according to Clavien and Dindon Classification treated conservatively without need for further operation. Four patients had transitional cell carcinoma and one Squamous cell carcinoma types. Everyone had negative resection margin while only two had negative lymph node. The median survival years in our study was 2.5 years, the overall survival rates at 2 years were 60%, 40% at 3 years and 20 at 5years. 2 patients die after one year due to renal failure and intercurrent disease. Conclusion: Laparoscopic radical cystectomy carried lower morbidity and cancerological outcome compare to open surgery making it a good alternative for bladder oncologic surgery.
References
[1]
Alfred Witjes, J., Lebret, T., Compérat, E.M., et al. (2017) Updated 2016 EAU Guidelines on Muscle-Invasive and Metastatic Bladder Cancer. European Urology, 71, 462-475. http://www.ncbi.nlm.nih.gov/pubmed/27375033 https://doi.org/10.1016/j.eururo.2016.06.020
[2]
Stephenson, A.J., Lerner, S.P. and Chen, W. (2019) Radical Cystectomy and Bladder-Sparing Treatments for Urothelial Bladder Cancer. Uptodate Inc., Waltham. https://www.uptodate.com
[3]
Tyritzis, S.I. and Wiklund, N.P. (2018) Is the Open Cystectomy Era over? An Update on the Available Evidence. International Journal of Urology, 25, 187-195. https://doi.org/10.1111/iju.13497
[4]
Shabsigh, A., Korets, R., Vora, K.C., Brooks, C.M., Cronin, A.M., Savage, C., et al. (2009) Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting Methodology. European Urology, 55, 164-176. https://doi.org/10.1016/j.eururo.2008.07.031
[5]
Hautmann, R.E., de Petriconi, R.C. and Volkmer, B.G. (2011) 25 Years of Experience with 1,000 Neobladders: Long-Term Complications. Journal of Urology, 185, 2207-2212. https://doi.org/10.1016/j.juro.2011.02.006
[6]
Rouprêt, M. and Lesur, G. (2008) Place de la cystectomie radicale par voie laparo-scopique dans le traitement des carcinomes urothéliaux infiltrants de vessie. Progrès en Urologie, 18, 145-151. https://doi.org/10.1016/j.purol.2007.08.001
[7]
Sánchez de Badajoz, E., Gallego Perales, J.L., Reche Rosado, A., Gutierrez de la Cruz, J.M. and Jimenez Garrido, A. (1995) Laparoscopic Cystectomy and Ileal Conduit: Case Report. Journal of Endourology, 9, 59-62. https://doi.org/10.1089/end.1995.9.59
[8]
Aron, M., Lerner, S.P., Gill, I.S. and Chen, W. (2019) Laparoscopic/Robotic-Assisted Radical Cystectomy. Uptodate Inc., Waltham. https://www.uptodate.com
[9]
Tamhankar, A.S., Thurtle, D., Hampson, A., et al. (2021) Radical Cystectomy in England from 2013 to 2019 on 12,644 Patients: An Analysis of National Trends and Comparison of Surgical Approaches Using Hospital Episode Statistics Data. BJUI Compass, 2, 338-347. https://doi.org/10.1002/bco2.79
[10]
Hirobe, M., Tanaka, T., Shindo, T., et al. (2018) Complications within 90 Days after Radical Cystectomy for Bladder Cancer: Results of a Multicenter Prospective Study in Japan. International Journal of Clinical Oncology, 23, 734-741. https://doi.org/10.1007/s10147-018-1245-z
[11]
Cassim, F., Sinha, S., et al. (2018) The First Series of Laparoscopic Radical Cystectomies Done in South Africa. South African Journal of Surgery, 56, 44-49.
[12]
Ashmawy, A.A., Assem, A., Abd El Hamid, M., et al. (2020) Impact of Clinical Stage on the Outcome of Laparoscopic Radical Cystectomy: A Prospective Cohort Study. African Journal of Urology, 26, Article No. 5. https://doi.org/10.1186/s12301-020-0017-y
[13]
Aziz, A., May, M., Burger, M., Palisaar, R.J., Trinh, Q.D., Fritsche, H.M., et al. (2014) Prediction of 90-Day Mortality after Radical Cystectomy for Bladder Cancer in a Prospective European Multicenter Cohort. European Urology, 66, 156-163. https://doi.org/10.1016/j.eururo.2014.02.022
[14]
Kader, A.K., Richards, K.A., Krane, L.S., Pettus, J.A., Smith, J.J. and Hemal, A.K. (2013) Robot-Assisted Laparoscopic vs Open Radical Cystectomy: Comparison of Complications and Perioperative Oncological Outcomes in 200 Patients. BJU International, 112, E290-E294. https://doi.org/10.1111/bju.12167
[15]
Lotan, Y., Choueiri, T.K., Lerner, S.P. and Shah, S. (2021) Clinical Presentation, Diagnosis, and Staging of Bladder Cancer. Uptodate Inc., Waltham. https://www.uptodate.com
Waingankar, N., Mallin, K., Smaldone, M., Egleston, B.L., Higgins, A., Winchester, D.P., et al. (2017) Assessing the Relative Influence of Hospital and Surgeon Volume on Short-Term Mortality after Radical Cystectomy. BJU International, 120, 239-245. https://doi.org/10.1111/bju.13804
[19]
Groeben, C., Koch, R., Baunacke, M., Wirth, M.P. and Huber, J. (2017) High Volume Is the Key for Improving In-Hospital Outcomes after Radical Prostatectomy: A Total Population Analysis in Germany from 2006 to 2013. World Journal of Urology, 35, 1045-1053. https://doi.org/10.1007/s00345-016-1982-4
[20]
Brierley, J., Gospodarowicz, M.K. and Wittekind, C.H. (2017) TNM Classification of Malignant Tumours. 8th Edition, John Wiley & Sons, Inc., Oxford. https://doi.org/10.1002/9780471420194.tnmc26.pub3
[21]
Flaig, T.W., Spiess, P.E., Agarwal, N., Bangs, R., Boorjian, S.A., Buyyounouski, M.K., et al. (2020) Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 18, 329-354. https://doi.org/10.6004/jnccn.2020.0011
[22]
Bowa, K., Mulele, C., Kachimba, J., Manda, E., Mapulanga, V. and Mukosai, S. (2018) A Review of Bladder Cancer in Sub-Saharan Africa: A Different Disease, with a Distinct Presentation, Assessment, and Treatment. Annals of African Medicine, 17, 99-105. https://doi.org/10.4103/aam.aam_48_17
[23]
Quinn, D.I., Lerner, S.P., Raghavan, D. and Ross, M.E. (2021) Non-Urothelial Bladder Cancer. Uptodate Inc., Waltham. https://www.uptodate.com
[24]
Saginala, K., Barsouk, A., Aluru, J.S., Rawla, P., Padala, S.A. and Barsouk, A. (2020) Epidemiology of Bladder Cancer. Medical Sciences, 8, Article No. 15. https://doi.org/10.3390/medsci8010015
[25]
Clavien, P.A., Barkun, J., De Oliveira, M.L., Vauthey, J.N., Dindo, D., Schulick, R.D., et al. (2009) The Clavien-Dindo Classification of Surgical Complications: 5-Year Experience. Annals of Surgery, 250, 187-196. https://doi.org/10.1097/SLA.0b013e3181b13ca2